637 INB-200: Phase I study of gene modified autologous gamma-delta (γδ) T cells in newly diagnosed glioblastoma (GBM) patients receiving maintenance temozolomide (TMZ): immunobiologic correlative data

• Trishna Goswami,
• Kate Rochlin,
• Lawrence Lamb,
• Mina Lobbous,
• Joy Shepard,
• Becca B Weekley,
• Caitlyn Lucas,
• Cathy Langford,
• Samantha Youngblood,
• Mariska Ter Haak,
• L Burt Nabors

Affiliations

Trishna Goswami

Aff9 grid.418152.bMedImmune Gaithersburg MD USA

Kate Rochlin

1IN8bio Inc, New York, NY, USA

Lawrence Lamb

1IN8bio Inc., Birmingham, AL, USA

Mina Lobbous

2University of Alabama at Birmingham, Birmingham, AL, USA

Joy Shepard

1IN8bio Inc., Birmingham, AL, USA

Becca B Weekley

1IN8bio Inc., Birmingham, AL, USA

Caitlyn Lucas

1IN8bio Inc., Birmingham, AL, USA

Cathy Langford

1IN8bio Inc., Birmingham, AL, USA

Samantha Youngblood

1IN8bio Inc., Birmingham, AL, USA

Mariska Ter Haak

3IN8Bio Inc., New York, NY, USA

L Burt Nabors

2University of Alabama at Birmingham, Birmingham, AL, USA